| 摘要 |
Disclosed are compositions and methods for the treatment of male impotence, wherein erectile dysfunction is alleviated by administering a pharmaceutically acceptable formulation containing prostaglandin PGE2. An antidote for the effects of administration of the PGE2, or for treating priapism of other etiology, is also disclosed.
|
